文献速递生殖医学妇科产科

间充质干细胞来源细胞外囊泡在性腺毒性暴露前生育力保护中的作用

Role of extracellular vesicles in fertility preservation before gonadotoxic exposures to the ovaries and testes.
PubMed 文献 · Hum Reprod · 2026-01-01

本文综述间充质干细胞来源细胞外囊泡(MSC-EVs)在生育力保护中的潜力。临床前动物模型显示,EVs对化疗所致卵巢和睾丸损伤具有保护与再生作用,可作为无细胞疗法在无需手术或不延迟癌症治疗的情况下保护女性卵巢功能和男性精子发生。未来需临床试验确认其安全性和有效性。

要点

  • MSC-EVs在动物模型中保护化疗所致卵巢和睾丸损伤。
  • EVs为无细胞疗法,无需手术或不延迟癌症治疗。
  • 相较干细胞疗法,EVs免疫排斥风险更低且可靶向治疗。

核心结论

  • MSC来源细胞外囊泡是有前景的生育力保护新策略,但尚需临床试验确认安全性和有效性。

研究设计与样本

  • 综述汇总临床前动物模型研究,未报告具体样本量。

主要发现

  • 临床前研究显示EVs在化疗诱导的卵巢和睾丸损伤动物模型中具有保护和再生特性。
  • EVs可潜在保护女性卵巢功能和男性精子发生,无需手术或延迟癌症治疗。
  • MSC-EVs相较传统干细胞疗法具有免疫排斥风险更低、靶向治疗和避免干细胞相关安全顾虑的优势。

临床怎么用

  • 肿瘤生育力保护场景下,MSC-EVs可作为无需手术且不延迟癌症治疗的无细胞候选疗法。
  • 未来可通过基因工程或细胞预处理增强MSC-EVs靶向特定组织的治疗潜力。

局限性

  • 现有证据主要来自临床前动物模型,尚缺乏临床试验确认安全性和有效性。
  • 需进一步研究聚焦早发性卵巢功能不全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fertility preservation remains a significant concern for individuals undergoing gonadotoxic treatments. While traditional fertility preservation techniques are well-established, these methods can be time-consuming and limited by various medical or logistical barriers. In recent years, the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) has emerged as a promising, paradigm-shifting approach in fertility preservation. Preclinical studies have demonstrated the protective and regenerative properties of EVs in chemotherapy-induced ovarian and testicular damage in animal models. EVs provide a cell-free therapy that can potentially preserve ovarian function in females and spermatogenesis in males without the need for surgery or delay in cancer treatment. Additionally, using MSC-derived EVs offers advantages over traditional stem cell therapies, such as a reduced risk of immune rejection, targeted treatment, and avoidance of safety concerns associated with stem cell-based therapies. Future directions include enhancing the therapeutic potential of MSC-derived EVs through genetic engineering or cell priming techniques to target specific tissues and further optimize their utilization in fertility preservation. Given the potential of MSC-derived EVs to protect fertility in both females and males, this approach could revolutionize treatment in oncofertility. Further research, including clinical trials, is necessary to confirm the safety and efficacy of MSC-derived EVs, focusing on premature ovarian insufficiency. Looking ahead, MSC-derived EVs could revolutionize fertility preservation, offering hope for cancer patients and individuals exposed to various environmental risks affecting reproduction, including in space exploration, where protection from cosmic radiation is essential.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cetin E, Alsoud LO, El Mahi Y, et al. Role of extracellular vesicles in fertility preservation before gonadotoxic exposures to the ovaries and testes. Hum Reprod. 2026. PMID: 41632688. doi:10.1093/humrep/deag004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。